Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$65.21
pos +0.59
+0.91%
Today's Range: 64.80 - 65.50 | ESRX Avg Daily Volume: 4,965,600
Last Update: 06/28/17 - 4:00 PM EDT
Volume: 2,208,448
YTD Performance: -6.06%
Open: $64.86
Previous Close: $64.62
52 Week Range: $65.55 - $94.22
Oustanding Shares: 593,527,000
Market Cap: 38,887,889,040
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 7
Moderate Buy 0 0 0 0
Hold 8 9 9 7
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.46 2.49 2.49 2.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 11.96
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
11.96 12.00 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.03% -11.73% -7.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.40 0.00 -0.01
Net Income 37.10 0.80 0.21
EPS 51.40 1.40 0.33
Earnings for ESRX:
EBITDA 7.24B
Revenue 100.29B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.71 $1.88 $6.97 $7.65
Number of Analysts 12 10 13 12
High Estimate $1.73 $1.93 $7.01 $7.81
Low Estimate $1.70 $1.85 $6.90 $7.50
Prior Year $1.57 $1.74 $6.39 $6.97
Growth Rate (Year over Year) 9.08% 8.33% 9.03% 9.84%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
I was pleasantly surprised to see that the candies are still crushing it.

When to Ignore the Bad News Real Money Pro($)

Fallout from dispute with Anthem, its largest customer, presents an opportunity.
Bearish
Apr 26, 2017 | 9:02 AM EDT
Edward Jones downgraded Express Scripts to "Hold" from "Buy."
* Biotech (Allergan (AGN) , Celgene (CELG) and Gilead Sciences (GILD) ) * Speculative biotech ( ZIOPHARM Oncology (ZIOP) ,   SAGE Therapeutics (SAGE) , Intrexon (XON) , Valeant Pharmaceuticals (VRX) ,   ACADIA Pharmaceuticals (ACAD) , FibroGen  (FGEN) ). * DuPont (DD) , Netflix (NFLX) , Baidu (BIDU) , Radian (RDN) and Biogen   (BIIB) . * New tech - (T)FANG (TSLA) , (FB) , (AAPL) , (NFLX) , (GOOGL) . * Chipotle Mexican Grill (
Its earnings are more than double what they were five years ago, but the stock price is the same.
Bearish
Mar 15, 2017 | 6:49 AM EDT
ESRX was downgraded from Market Perform to Underperform, Wells Fargo said. Loss of the Anthem contract could hurt annual earnings by 20...
The stock has taken a beating, but users of Afrezza are loyal to the drug.
Six reasons why the Nasdaq 100 ETF seems ready to pull back.
Microsoft (MSFT) , which makes up about 8.6% of the index. Amazon (AMZN) , which has about a 6.4% weighting. Cisco (CSCO) , which accounts for about 2.7% on QQQ. I've previously written that I'm bearish on Cisco on an intermediate-term basis. Non-Tech QQQ Stocks Look Iffy, Too Some non-tech QQQ components could weigh down the ETF in 2017 as well. These include biotech and health care companies such as Amgen (AMGN) , Biogen (BIIB) , Celgene (CELG) , Express Scripts (ESRX) and others, which all could suffer if Trump tries to limit drug-price increases. Comcast (CMCSA) also represents a relatively large QQQ weighting (about 3%), but the cable giant could suffer from continued "cord cutting" by consumers. Tax Cuts Won't Help QQQ Stocks Trump's plan to lower the effective U.S. corporate tax rate won't materially benefit QQQ components. After all, large tech and health care firms in the Nasdaq 100 already g

Columnist Conversations

GLW is up over 1.75% as we head into the final hour. The stock closed last week at new 2017 highs and is pushi...
Nice bump for X today. Stock is up over 5% and is headed for its best close of the month. Still basing but imp...
The Semiconductor sector (SMH) is rebounding off its 50-day moving average, and I'm picking at a few different...
we like this chart setup here and with earnings Thurs, we'll take a position. BOUGHT STZ AUG 185 CALL AT 6...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.